Tcg Crossover Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $771 Million distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $95.2M, Cogent Biosciences, Inc. with a value of $75.2M, Edgewise Therapeutics, Inc. with a value of $56.4M, Silence Therapeutics PLC with a value of $55.2M, and Savara Inc with a value of $52.4M.
Examining the 13F form we can see an increase of $103M in the current position value, from $668M to 771M.
Tcg Crossover Management, LLC is based out at Palo Alto, CA
Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.